NumbersUSA Looks Forward to Helping to Restore Immigration Credibility
President-elect Trump has a clear mandate from the American people to restore the credibility of our immigration system, ensuring that it functions first and foremost in the interest of the American people.
Trump has promised to reestablish the rule of law, both at the border and in the interior of the country. His running mate, JD Vance, has promised that "we're done importing foreign labor, we're going to fight for American citizens and their good jobs and their good wages."
These messages resonate with voters appalled by the past four years of the Biden-Harris administration's open border policies, which have brought in the largest number of immigrants – both legal and illegal – of any single-term administration in history.
America was on pace to add 35 million new foreign residents in a single decade, an unsustainable increase that would make it harder for Americans to afford housing, secure good-paying jobs, and improve their quality of life.
NumbersUSA looks forward to working with President-elect Trump, Vice President-elect Vance, and members of both parties in Congress to make reforms that limit immigration a reality.
On day one in office, Trump can end programs put in place by the Biden administration that incentivized and rewarded illegal immigration. As Speaker Johnson has indicated, the priority for the House of Representatives is to reintroduce and pass H.R. 2 – a crucial first step.
We also urge the Trump administration and Congress to effect more lasting reforms by pushing for NumbersUSA's Great Solutions in legislation.
About NumbersUSA
NumbersUSA is a nonpartisan, nonprofit organization that supports a balanced immigration system that welcomes the spouses and minor children of
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/numbersusa-looks-forward-to-helping-to-restore-immigration-credibility-302322890.html
SOURCE NumbersUSA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formu
- InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China
- New Plaistow HQ Positions Bradford Constrution to Build ADUs Across Two States
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share